Maltese national focal point
The Maltese national focal point is based within the Ministry for Social Policy and Children's Rights and is part of the National Coordinating Unit on Drugs and Alcohol. It started its operations in June 2004 as a result of a Twinning Light Project with the Netherlands.
News
Events, meetings and visits
- Potent synthetic substances, new drug mixtures and changing patterns of use pose growing threat in Europe
- Coming soon: European Drug Report 2024 to be released on 11 June
- Celebrating European Day of Languages: EMCDDA multilingual drug glossary unveiled
- Reitox network meets to showcase 2022 highlights, new digital resources and plan future activities
- 25 years of early warning and response to new psychoactive substances in Europe
- Penalties for drug law offences in Europe ‘at a glance’ — new countries added to online tool
Events
Events, meetings and visits
- Reitox academy on drug checking (03.10.2024 to 04.10.2024, Utrecht, The Netherlands)
- Reitox Academy on ‘Implementing futures/foresight in the drug field, with a focus on synthetic drugs’ (27.06.2024 to 28.06.2024, Dublin, Ireland)
- 70th Heads of Reitox national focal points meeting (21.05.2024 to 23.05.2024, Lisbon, Portugal)
- Launch event: European Drug Report 2024 (11.06.2024, Online)
- Expert meeting on drug-related infectious diseases (DRID) 2024 (07.11.2024 to 08.11.2024, EMCDDA, Lisbon)
- Treatment Demand Indicator (TDI) expert meeting 2024 (17.09.2024 to 18.09.2024, Lisboa, Portugal)
Publications
Publications related to this partner
Drug-induced deaths are those that are directly attributable to the use of drugs. On this page, you can find the latest analysis of drug-induced deaths in Europe, including key data on overdose deaths, substances implicated and more.
People who inject drugs are at risk of contracting infections through the sharing of drug use paraphernalia. On this page, you can find the latest analysis of drug-related infectious diseases in Europe, including key data on infections with HIV and hepatitis B and C viruses.
Harm reduction encompasses interventions, programmes and policies that seek to reduce the health, social and economic harms of drug use to individuals, communities and societies. On this page, you can find the latest analysis of harm reduction interventions in Europe, including key data on o
MDMA is a synthetic drug chemically related to the amphetamines, but with somewhat different effects. In Europe, MDMA use has generally been associated with episodic patterns of consumption in the context of nightlife and entertainment settings.
The market for new psychoactive substances is characterised by the large number of substances that have emerged, with new ones being detected each year.
This page draws on the latest data available to provide an overview of the current situation and emerging drug issues affecting Europe, with a focus on the year up to the end of 2023.
Document library
Relevant external documents or commissioned reports from the EMCDDA Document library
- Government of Malta (2023) Malta's National Drugs Policy 2023-33 ( )
- Social reintegration situation in reporting countries, compiled from 2012 national reports ( )
- Conclusions of the 39th meeting of Reitox Heads of Focal Points ( )
- Conclusions of the 40th meeting of Reitox Heads of Focal Points ( )
- Conclusions of the 41st meeting of Reitox Heads of Focal Points ( )
- Conclusions of the 42nd meeting of Reitox Heads of Focal Points ( )
Media library
Related photos, infographics and videos from our Media library
Contact information
National Anti-Drug Agency
Mr Manuel Gellel
Valletta
Malta